Hassan Fred 4

What Happened
Hassan Fred, a director of Precigen, received equity awards on March 10, 2026. He was issued 17,948 common shares at $3.51 per share (total value reported as $62,997) and was granted 35,612 and 41,073 restricted stock units (RSUs) (total 76,685 RSUs) at $0 (derivative awards). The 17,948 shares were issued in lieu of his annual retainer; the RSUs are contingent rights to receive one share each and vest in full on March 10, 2027. These were awards/compensation (transaction code A), not open-market purchases or sales.

Key Details

• Transaction date: March 10, 2026; Form 4 filed March 12, 2026 (timely filing).
• Shares issued/acquired: 17,948 common shares @ $3.51 = $62,997.
• Derivative awards: 35,612 RSUs and 41,073 RSUs @ $0 (total 76,685 RSUs).
• RSU terms: Each RSU converts to one share; vesting in full on March 10, 2027 (Footnotes F2, F3).
• Reason for share issuance: Shares issued in lieu of annual retainer of $63,000 (Footnote F1).
• Shares owned after transaction: Not disclosed in the provided filing excerpt.

Context
Equity grants like these are routine director compensation and reflect pay structure rather than an explicit buy/sell signal. RSUs are derivative awards that do not become actual shares until they vest (here, one year later). No sale or open-market purchase occurred in this filing.